286 related articles for article (PubMed ID: 17143008)
1. Healing impairment effect of cyclooxygenase inhibitors on dextran sulfate sodium-induced colitis in rats.
Tsubouchi R; Hayashi S; Aoi Y; Nishio H; Terashima S; Kato S; Takeuchi K
Digestion; 2006; 74(2):91-100. PubMed ID: 17143008
[TBL] [Abstract][Full Text] [Related]
2. Aggravation by selective COX-1 and COX-2 inhibitors of dextran sulfate sodium (DSS)-induced colon lesions in rats.
Okayama M; Hayashi S; Aoi Y; Nishio H; Kato S; Takeuchi K
Dig Dis Sci; 2007 Sep; 52(9):2095-103. PubMed ID: 17429720
[TBL] [Abstract][Full Text] [Related]
3. The COX-2 inhibitor, rofecoxib, ameliorates dextran sulphate sodium induced colitis in mice.
Martín AR; Villegas I; Alarcón de la Lastra C
Inflamm Res; 2005 Apr; 54(4):145-51. PubMed ID: 15883736
[TBL] [Abstract][Full Text] [Related]
4. Roles of nitric oxide (NO) and NO synthases in healing of dextran sulfate sodium-induced rat colitis.
Aoi Y; Terashima S; Ogura M; Nishio H; Kato S; Takeuchi K
J Physiol Pharmacol; 2008 Jun; 59(2):315-36. PubMed ID: 18622048
[TBL] [Abstract][Full Text] [Related]
5. Roles of endogenous prostaglandins and cyclooxygenase izoenzymes in mucosal defense of inflamed rat stomach.
Takeeda M; Hayashi Y; Yamato M; Murakami M; Takeuchi K
J Physiol Pharmacol; 2004 Mar; 55(1 Pt 2):193-205. PubMed ID: 15082878
[TBL] [Abstract][Full Text] [Related]
6. Roles of endogenous prostaglandins and cyclooxygenase isozymes in healing of indomethacin-induced small intestinal lesions in rats.
Hatazawa R; Ohno R; Tanigami M; Tanaka A; Takeuchi K
J Pharmacol Exp Ther; 2006 Aug; 318(2):691-9. PubMed ID: 16699067
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic treatment with ampicillin accelerates the healing of colonic damage impaired by aspirin and coxib in the experimental colitis. Importance of intestinal bacteria, colonic microcirculation and proinflammatory cytokines.
Zwolinska-Wcislo M; Krzysiek-Maczka G; Ptak-Belowska A; Karczewska E; Pajdo R; Sliwowski Z; Urbanczyk K; Drozdowicz D; Konturek SJ; Pawlik WW; Brzozowski T
J Physiol Pharmacol; 2011 Jun; 62(3):357-68. PubMed ID: 21893697
[TBL] [Abstract][Full Text] [Related]
8. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events.
Tanaka A; Hase S; Miyazawa T; Ohno R; Takeuchi K
J Pharmacol Exp Ther; 2002 Dec; 303(3):1248-54. PubMed ID: 12438549
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of both COX-1 and COX-2 and resulting decrease in the level of prostaglandins E2 is responsible for non-steroidal anti-inflammatory drug (NSAID)-dependent exacerbation of colitis.
Tanaka K; Suemasu S; Ishihara T; Tasaka Y; Arai Y; Mizushima T
Eur J Pharmacol; 2009 Jan; 603(1-3):120-32. PubMed ID: 19101538
[TBL] [Abstract][Full Text] [Related]
10. Nonsteroidal anti-inflammatory drug-activated gene-1 plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer healing.
Colucci R; Antonioli L; Bernardini N; Ippolito C; Segnani C; Awwad O; Tuccori M; Blandizzi C; Scarpignato C; Fornai M
J Pharmacol Exp Ther; 2012 Jul; 342(1):140-9. PubMed ID: 22495067
[TBL] [Abstract][Full Text] [Related]
11. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
12. Aggravation of inflammatory bowel disease by cyclooxygenase-2 inhibitors in rats.
Singh VP; Patil CS; Jain NK; Kulkarni SK
Pharmacology; 2004 Oct; 72(2):77-84. PubMed ID: 15331912
[TBL] [Abstract][Full Text] [Related]
13. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2.
Reuter BK; Asfaha S; Buret A; Sharkey KA; Wallace JL
J Clin Invest; 1996 Nov; 98(9):2076-85. PubMed ID: 8903327
[TBL] [Abstract][Full Text] [Related]
14. Rosuvastatin, a new HMG-CoA reductase inhibitor, reduces the colonic inflammatory response in dextran sulfate sodium-induced colitis in mice.
Naito Y; Katada K; Takagi T; Tsuboi H; Isozaki Y; Handa O; Kokura S; Yoshida N; Ichikawa H; Yoshikawa T
Int J Mol Med; 2006 Jun; 17(6):997-1004. PubMed ID: 16685407
[TBL] [Abstract][Full Text] [Related]
15. Dual role of endogenous nitric oxide in development of dextran sodium sulfate-induced colitis in rats.
Rumi G; Tsubouchi R; Nishio H; Kato S; Mózsik G; Takeuchi K
J Physiol Pharmacol; 2004 Dec; 55(4):823-36. PubMed ID: 15613746
[TBL] [Abstract][Full Text] [Related]
16. Differential role of cyclooxygenase 1 and 2 isoforms in the modulation of colonic neuromuscular function in experimental inflammation.
Fornai M; Blandizzi C; Antonioli L; Colucci R; Bernardini N; Segnani C; De Ponti F; Del Tacca M
J Pharmacol Exp Ther; 2006 Jun; 317(3):938-45. PubMed ID: 16474005
[TBL] [Abstract][Full Text] [Related]
17. Possible role of mucosal mast cells in the recovery process of colitis induced by dextran sulfate sodium in rats.
Iba Y; Sugimoto Y; Kamei C; Masukawa T
Int Immunopharmacol; 2003 Apr; 3(4):485-91. PubMed ID: 12689654
[TBL] [Abstract][Full Text] [Related]
18. Involvement of cyclooxygenase (COX)-2 products in acceleration of ulcer healing by gastrin and hepatocyte growth factor.
Brzozowski T; Konturek PC; Konturek SJ; Pajdo R; Schuppan D; Drozdowicz D; Ptak A; Pawlik M; Nakamura T; Hahn EG
J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):751-73. PubMed ID: 11192947
[TBL] [Abstract][Full Text] [Related]
19. An orally active matrix metalloproteinase inhibitor, ONO-4817, reduces dextran sulfate sodium-induced colitis in mice.
Naito Y; Takagi T; Kuroda M; Katada K; Ichikawa H; Kokura S; Yoshida N; Okanoue T; Yoshikawa T
Inflamm Res; 2004 Sep; 53(9):462-8. PubMed ID: 15550999
[TBL] [Abstract][Full Text] [Related]
20. Ulcerogenic influence of selective cyclooxygenase-2 inhibitors in the rat stomach with adjuvant-induced arthritis.
Kato S; Ogawa Y; Kanatsu K; Okayama M; Watanabe T; Arakawa T; Takeuchi K
J Pharmacol Exp Ther; 2002 Nov; 303(2):503-9. PubMed ID: 12388629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
